high-density lipoprotein ( HDL ) cholesterol increased ( @ @ to @ @ mg/dl , p < @ ) and triglycerides decreased ( from @ @ mg/dl to @ @ mg/dl , p < @ ) in the ezetimibe + fenofibrate group , whereas both parameters remained unchanged in the pravastatin group .